Green Synthesis, Biological Evaluation, and Molecular Docking of 4'-(Substituted Phenyl)Spiro[Indoline-3,3'-[1,2,4]Triazolidine]-2,5'-Diones

References

• X. Guo, J. Wang, C. Su, C. Liu, X. Ma, Z. Yu, J. Li, X. Wang, W. Xiang, and S.A. Huang, “Unique Spiro-β-Triazinedione-γ-Hydantoin Type Alkaloid with Antiviral Activity against Tobacco Mosaic Virus from Streptomyces gamaensis,” Organic Chemistry Frontiers 6, no. 18 (2019): 3215–9. doi:10.1039/C9QO00742C.
   Web of Science ®Google Scholar
• E. Chupakhin, O. Babich, A. Prosekov, L. Asyakina, and M. Krasavin, “Spirocyclic Motifs in Natural Products,” Molecules 24, no. 22 (2019): 4165. doi:10.3390/molecules24224165.
   PubMed Web of Science ®Google Scholar
• S. Haddad, S. Boudriga, F. Porzio, A. Soldera, M. Askri, M. Knorr, Y. Rousselin, M.M. Kubicki, C. Golz, and C. Strohmann, “Regio- and Stereoselective Synthesis of Spiropyrrolizidines and Piperazines through Azomethine Ylide Cycloaddition Reaction,” The Journal of Organic Chemistry 80, no. 18 (2015): 9064–75. doi:10.1021/acs.joc.5b01399.
   PubMed Web of Science ®Google Scholar
• E.G. Prado, M.D.G. Gimenez, R.D.P. Vázquez, J.L.E. Sánchez, and M.T.S. Rodríguez, “Antiproliferative Effects of Mitraphylline, a Pentacyclic Oxindole Alkaloid of Uncaria tomentosa on Human Glioma and Neuroblastoma Cell Lines,” Phytomedicine 4, no. 14 (2007): 280. doi:10.1016/j.phymed.2006.12.023.
   Google Scholar
• Y.L. Tay, A. Amanah, M.I. Adenan, H.A. Wahab, and M.L. Tan, “Mitragynine, an Euphoric Compound Inhibits hERG1a/1b Channel Current and Upregulates the Complexation of hERG1a-Hsp90 in HEK293-hERG1a/1b Cells,” Scientific Reports 9, no. 1 (2019): 19757. doi:10.1038/s41598-019-56106-6.
   PubMed Web of Science ®Google Scholar
• F. Salim, N.H. Ismail, K. Awang, and R. Ahmad, “Rauniticine-allo-Oxindole B and Rauniticinic-Allo Acid B, New Heteroyohimbine-Type Oxindole Alkaloids from the Stems of Malaysian Uncaria longiflora var. pteropoda,” Molecules 16, no. 8 (2011): 6541–8. doi:10.3390/molecules16086541.
   PubMed Web of Science ®Google Scholar
• M.N. Ballester Roig, T. Leduc, C.C. Areal, and V. Mongrain, “Cellular Effects of Rhynchophylline and Relevance to Sleep Regulation,” Clocks & Sleep 3, no. 2 (2021): 312–41. doi:10.3390/clockssleep3020020.
   PubMedGoogle Scholar
• M.L. Hillwig, H.A. Fuhrman, K. Ittiamornkul, T.J. Sevco, D.H. Kwak, and X. Liu, “Identification and Characterization of a Welwitindolinone Alkaloid Biosynthetic Gene Cluster in Stigonematalean Cyanobacterium Hapalosiphon welwitschii,” Chembiochem 15, no. 5 (2014): 665–9. doi:10.1002/cbic.201300794.
   PubMed Web of Science ®Google Scholar
• C.B. Cui, H. Kakeya, and H. Osada, “Novel Mammalian Cell Cycle Inhibitors, Spirotryprostatins A and B, Produced by Aspergillus fumigatus, Which Inhibit Mammalian Cell Cycle at G2/M Phase,” Tetrahedron 52, no. 39 (1996): 12651–66. doi:10.1016/0040-4020(96)00737-5.
   Web of Science ®Google Scholar
• S. Wang, W. Sun, Y. Zhao, D. McEachern, I. Meaux, C. Barrière, J.A. Stuckey, J.L. Meagher, L. Bai, L. Liu, et al., “SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression,” Cancer Research 74, no. 20 (2014): 5855–65. doi:10.1158/0008-5472.CAN-14-0799.
   PubMed Web of Science ®Google Scholar
• Andrew Fensome, William R. Adams, Andrea L. Adams, Tom J. Berrodin, Jeff Cohen, Christine Huselton, Arthur Illenberger, Jeffrey C. Kern, Valerie A. Hudak, Michael A. Marella, et al., “Design, Synthesis, and SAR of New Pyrrole-Oxindole Progesterone Receptor Modulators Leading to 5-(7-Fluoro-3,3-Dimethyl-2-Oxo-2,3-Dihydro-1H-Indol-5-yl)-1-Methyl-1H-Pyrrole-2-Carbonitrile (WAY-255348,” Journal of Medicinal Chemistry 51, no. 6 (2008): 1861–73. doi:10.1021/jm701080t.
   PubMed Web of Science ®Google Scholar
• Viktor V. Vintonyak, Karin Warburg, Holger Kruse, Stefan Grimme, Katja Hübel, Daniel Rauh, and Herbert Waldmann, “Identification of Thiazolidinones Spiro-Fused to Indolin-2-Ones as Potent and Selective Inhibitors of the Mycobacterium tuberculosis Protein Tyrosine Phosphatase B,” Angewandte Chemie 122, no. 34 (2010): 6038–41. doi:10.1002/ange.201002138.
   Google Scholar
• B.K.S. Yeung, B. Zou, M. Rottmann, S.B. Lakshminarayana, S.H. Ang, S.Y. Leong, J. Tan, J. Wong, S. Keller-Maerki, C. Fischli, et al., “Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria,” Journal of Medicinal Chemistry 53, no. 14 (2010): 5155–64. doi:10.1021/jm100410f.
   PubMed Web of Science ®Google Scholar
• T.D. Bagul, G. Lakshmaiah, T. Kawabata, and K. Fuji, “Total Synthesis of Spirotryprostatin B via Asymmetric Nitroolefination,” Organic Letters 4, no. 2 (2002): 249–51. doi:10.1021/ol016999s.
   PubMed Web of Science ®Google Scholar
• S.R. Yong, M.C. Williams, S.G. Pyne, A.T. Ung, B.W. Skelton, A.H. White, and P. Turner, “Synthesis of 2-Azaspiro[4.4]Nonan-1-Ones via Phosphine-Catalysed [3 + 2]-Cycloadditions,” Tetrahedron 61, no. 34 (2005): 8120–9. doi:10.1016/j.tet.2005.06.050.
   Web of Science ®Google Scholar
• R.T. Ruck, M.A. Huffman, M.M. Kim, M. Shevlin, W.V. Kandur, and I.W. Davies, “Palladium-Catalyzed Tandem Heck Reaction/C-H Functionalization-Preparation of Spiro-Indane-Oxindoles,” Angewandte Chemie (International ed. in English) 47, no. 25 (2008): 4711–4. doi:10.1002/anie.200800549.
   PubMed Web of Science ®Google Scholar
• Chitrala Teja, Spoorthy N. Babu, Ayesha Noor, J. Arul Daniel, S. Asha Devi, and Fazlur Rahman Nawaz Khan, “Cu/TEMPO Catalyzed Dehydrogenative 1,3-Dipolar Cycloaddition in the Synthesis of Spirooxindoles as Potential Antidiabetic Agents,” RSC Advances 10, no. 21 (2020): 12262–71. doi:10.1039/d0ra01553a.
   PubMed Web of Science ®Google Scholar
• T. Kawasaki, A. Ogawa, R. Terashima, T. Saheki, N. Ban, H. Sekiguchi, K. Sakaguchi, and M. Sakamoto, “Synthesis of Diversely Functionalized Hexahydropyrrolo[2,3-b]Indoles Using Domino Reactions, Olefination, Isomerization and Claisen Rearrangement Followed by Reductive Cyclization,” The Journal of Organic Chemistry 70, no. 8 (2005): 2957–66. doi:10.1021/jo040289.
   PubMed Web of Science ®Google Scholar
• D.M. Morens, G.K. Folkers, and A.S. Fauci, “The Challenge of Emerging and Re-Emerging Infectious Diseases,” Nature 430, no. 6996 (2004): 242–9. doi:10.1038/nature02759.
   PubMed Web of Science ®Google Scholar
• Richard J. Fair and Yitzhak Tor, “Antibiotics and Bacterial Resistance in the 21st Century,” Perspectives in Medicinal Chemistry 6, no. 6 (2014): 25–64. doi:10.4137/PMC.S14459.
   PubMedGoogle Scholar
• M.J. Ahsan, G.J. Samy, K. Habibullah, M.S. Nomani, P. Saraswat, R. Gaur, and A. Singh, “Molecular Properties Prediction and Synthesis of Novel 1,3,4-Oxadiazole Analogues as Potent Antimicrobial and Antitubercular Agents,” Bioorganic & Medicinal Chemistry Letters 21, no. 24 (2011): 7246–50. doi:10.1016/j.bmcl.2011.10.057.
   PubMed Web of Science ®Google Scholar
• “Antibiotic Resistance Threats in The United States 2019,” The Full 2019 AR Threats Report, including methods and appendices, is available online at www.cdc.gov/DrugResistance/Biggest-Threats.html.
   Google Scholar
• D.E. Morris, D.W. Cleary, and S.C. Clarke, “Secondary Bacterial Infections Associated with Influenza Pandemics,” Frontier in Microbiology 8, no. 8 (2017): 1041. doi:10.3389/fmicb.2017.01041.
   PubMedGoogle Scholar
• J.M. Farrell, C.Y. Zhao, K.M. Tarquinio, and S.P. Brown, “Causes and Consequences of COVID-19-Associated Bacterial Infections,” Frontiers in Microbiology 12, no. 12 (2021): 682571. doi:10.3389/fmicb.2021.682571.
   PubMedGoogle Scholar
• B.J. Berger, F. Hussain, and K. Roistacher, “Bacterial Infections in HIV-Infected Patients,” Infectious Disease Clinics of North America Journal 8, no. 2 (1994): 449–65. doi:10.1016/S0891-5520(20)30600-0.
   PubMed Web of Science ®Google Scholar
• R. Sakhuja, S.S. Panda, L. Khanna, S. Khurana, and S.C. Jain, “Design and Synthesis of Spiro[Indole-Thiazolidine]Spiro[Indole-Pyrans]as Antimicrobial Agents,” Bioorganic & Medicinal Chemistry Letters 21, no. 18 (2011): 5465–9. doi:10.1016/j.bmcl.2011.06.121.
   PubMed Web of Science ®Google Scholar
• R.J. Shah, N.R. Modi, M.J. Patel, L.J. Patel, B. Chauhan, and M.M. Patel, “Design, Synthesis and in Vitro Antibacterial and Antifungal Activities of Some Novel Spiro[Azetidine-2,3′-Indole]-2,4(1′H)-Dione,” Medicinal Chemistry Research 20, no. 5 (2011): 587–94. doi:10.1007/s00044-010-9354-x.
   Web of Science ®Google Scholar
• M.S. Islam, A.M. Al-Majid, F.F. El-Senduny, F.A. Badria, A.F.M.M. Rahman, A. Barakat, and Y.A.M.M. Elshaier, “Synthesis, Anticancer Activity, and Molecular Modeling of New Halogenated Spiro[Pyrrolidine-Thiazolo-Oxindoles] Derivatives,” Applied Sciences 10, no. 6 (2020): 2170. doi:10.3390/app10062170.
   Google Scholar
• D. Lafitte, V. Lamour, P.O. Tsvetkov, A.A. Makarov, M. Klich, P. Deprez, D. Moras, C. Briand, and R. Gilli, “DNA Gyrase Interaction with Coumarin-Based Inhibitors: The Role of the Hydroxybenzoate Isopentenyl Moiety and the 5’-Methyl Group of the Noviose,” Biochemistry 41, no. 23 (2002): 7217–23. doi:10.1021/bi0159837.
   PubMed Web of Science ®Google Scholar
• Manohary Rajendram, Katherine A. Hurley, Marie H. Foss, Kelsey M. Thornton, Jared T. Moore, Jared T. Shaw, and Douglas B. Weibel, “Gyramides Prevent Bacterial Growth by Inhibiting DNA Gyrase and Altering Chromosome Topology,” ACS Chemical Biology 9, no. 6 (2014): 1312–9. doi:10.1021/cb500154m.
   PubMed Web of Science ®Google Scholar
• Mohamed Jawed Ahsan, Mohd Amir, Mohamed Afroz Bakht, Jeyabalan Govinda Samy, Mohamed Zaheen Hasan, and Md Shivli Nomani, “Synthesis and Antimicrobial Activity of N1-(3-Chloro-4-Flourophenyl)-N4-Substituted Semicarbazone Derivatives,” Arabian Journal of Chemistry 9 (2016): S861–S866. doi:10.1016/j.arabjc.2011.09.012.
   Web of Science ®Google Scholar
• J. Tiwari, M. Saquib, S. Singh, F. Tufail, J. Singh, and J. Singh, “Catalyst-Free Glycerol-Mediated Green Synthesis of 5′-Thioxospiro[Indoline-3,3′-[1,2,4]Triazolidin]-2-Ones/Spiro[Indoline-3,3′-[1,2,4]Triazolidine]-2,5′-Diones,” Synthetic Communications 47, no. 21 (2017): 1999–2006. doi:10.1080/00397911.2017.1359844.
   Web of Science ®Google Scholar
• A.H. Collins, Microbiological Methods. 2nd ed. London: Butterworth, 1976.
   Google Scholar
• R. Cruickshank, J.P. Duguid, B.P. Marmion, and R.H.A. Swain, Medicinal Microbiology. 12th ed. London: Churchill Livingstone, 1975, Vol. 2, p. 196.
   Google Scholar
• V. Gruppo, C.M. Johnson, K.S. Marietta, H. Scherman, E.E. Zink, D.C. Crick, L.B. Adams, I.M. Orme, and A.J. Lenaerts, “Rapid Microbiologic and Pharmacologic Evaluation of Experimental Compounds against Mycobacterium tuberculosis,” Antimicrobial Agents & Chemotherapy 4, no. 50 (2006): 1245. https://doi.org/10.1128/AAC.50.4.1245-1250.2006.
   Google Scholar
• Z.K. Khan, “In-Vitro and In-Vivo Screening Techniques for Bioactivity Screening and Evaluation,” Proceedings of Internationl Workshop UNIDO-CDRI (1997): 210.
   Google Scholar
• Varma, R.S., ed., Antifungal Agents: Past, Present and Future Prospects. Lucknow, India: National Academy of Chemistry & Biology, 1998.
   Google Scholar
• “AMDE Prediction Studies,” Available from: http://www.swissadme.ch/ (accessed July 14, 2021).
   Google Scholar
• A. Daina, O. Michielin, and V. Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7, no. 7 (2017): 42717. doi:10.1038/srep42717.
   PubMedGoogle Scholar
• C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings,” Advanced Drug Delivery Reviews 46, no. 1–3 (2001): 3–26. doi:10.1016/S0169-409X(00)00129-0.
   PubMed Web of Science ®Google Scholar
• Antoine Daina, and Vincent Zoete, “A BOILED-Egg to Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules,” ChemMedChem. 11, no. 11 (2016): 1117–21. doi:10.1002/cmdc.201600182.
   PubMed Web of Science ®Google Scholar
• “X-Ray Crystal of Cytochrome Bacterial DNA Gyrase (PDB ID: 1KZN),” https://www.rcsb.org/structure/1KZN (accessed on March 19, 2022).
   Google Scholar
• S.A. Elseginy, and M.M. Anwar, “Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation for Identification of a Novel DNA Gyrase B Inhibitor with Benzoxazine Acetamide Scaffold,” ACS Omega 7, no. 1 (2022): 1150–64. doi:10.1021/acsomega.1c05732.
   PubMed Web of Science ®Google Scholar
• S.A. Khan, A.M. Asiri, H.M. Basisi, M. Asad, M.E.M. Zayed, K. Sharma, and M.Y. Wani, “Synthesis and Evaluation of Quinoline-3-Carbonitrile Derivatives as Potential Antibacterial Agents,” Bioorganic Chemistry 88, no. 88 (2019): 102968. doi:10.1016/j.bioorg.2019.102968.
   PubMedGoogle Scholar